Cargando…

Clinical significance of cytokeratin 19 and OCT4 as survival markers in non-metastatic and metastatic breast cancer patients

INTRODUCTION: Cytokeratin 19 (CK19) is highly expressed in epithelial tumours such as breast cancer (BC). Octamer-binding transcription factor 4 (OCT4), a transcription factor of the POU (Pit-Oct-UNC) family, plays a criti-cal role in the self-renewal and maintenance of pluripotency of embryonic ste...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdelaziz, Lobna A., Ebian, Huda F., Harb, Ola A., Nosery, Yousef, Taha, Heba F., Nawar, Nashwa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2022
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052340/ https://www.ncbi.nlm.nih.gov/pubmed/35506041 http://dx.doi.org/10.5114/wo.2022.115678

Ejemplares similares

Serum Cytokeratin 18 as a Metastatic and Therapeutic Marker for Extramammary Paget’s Disease
por: URANO-TAKAOKA, Mariko, et al.
Publicado: (2022)

Cytokeratin-Positive Osteosarcoma Simulating Sarcomatoid Metastatic Carcinoma
por: Murtaza, Hamza, et al.
Publicado: (2020)

Tolerability and outcome of sunitinib by giving 4/2 schedule versus 2/1 schedule in metastatic renal cell carcinoma patients: a prospective randomized multi-centric Egyptian study
por: Abdelaziz, Lobna A., et al.
Publicado: (2021)

Prognostic significance of lymphocyte-to-monocyte ratio in patients with classical Hodgkin lymphoma before and after receiving first-line chemotherapy
por: Taha, Heba F., et al.
Publicado: (2022)

EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer
por: Serrano, Maria J., et al.
Publicado: (2014)

Cytokeratin 7-positive/cytokeratin 20-negative cecal adenocarcinoma metastatic to the uterine cervix: a case report
por: Toyoshima, Masafumi, et al.
Publicado: (2016)

Metastatic Seminoma with Positive Staining of Cytokeratin and MOC31: A Diagnostic Pitfall
por: Fan, Jiaming, et al.
Publicado: (2021)

Combined immunohistochemistry of β-catenin, cytokeratin 7, and cytokeratin 20 is useful in discriminating primary lung adenocarcinomas from metastatic colorectal cancer
por: Ikeda, Satoshi, et al.
Publicado: (2006)

Stem Cell Markers (Cytokeratin 17 and Cytokeratin 19) in Scarring and Nonscarring Alopecia
por: El Sakka, Dalia, et al.
Publicado: (2016)

Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients
por: Deng, Glenn, et al.
Publicado: (2008)

The prognostic and predictive significance of cytokeratin 5/6 and epidermal growth factor receptor in metastatic triple-negative breast cancer treated with maintenance capecitabine
por: Zhu, Yiping, et al.
Publicado: (2021)

Cytokeratin immunoprofile of primary and metastatic adenoid cystic carcinoma of salivary glands: a report of two cases
por: Nagano, Cibele Pidorodeski, et al.
Publicado: (2016)

Prognostic significance of nutritional markers in metastatic gastric and esophageal adenocarcinoma
por: Ma, Lucy X., et al.
Publicado: (2020)

The Significance of Caspase-Cleaved Cytokeratin 18 in Pleural Effusion
por: Lee, Keu Sung, et al.
Publicado: (2014)

Peripheral blood CD26 positive leukemic stem cells as a possible diagnostic and prognostic marker in chronic myeloid leukemia
por: Ebian, Huda F, et al.
Publicado: (2022)

Cytokeratin and mammaglobin as tumor markers in patients with high risk breast cancer
por: Ferrucci, PF, et al.
Publicado: (2000)

Utility of thyroid transcription factor-1 and cytokeratin 20 in identifying the origin of metastatic carcinomas of cervical lymph nodes.
por: Roh, Mee Sook, et al.
Publicado: (2002)

Presence of Cytokeratin 19-Expressing Cholangiocarcinoma-Like Tumour in a Liver Metastatic Lesion of Rectal Neuroendocrine Tumour
por: Ishii, Norihiro, et al.
Publicado: (2016)

Suppression of OCT-1 in Metastatic Breast Cancer Cells Reduces Tumor Metastatic Potential, Hypoxia Resistance, and Drug Resistance
por: Stepchenko, Alexander G., et al.
Publicado: (2022)

Cytokeratin 5/6 and cytokeratin 8/18 expression in triple negative breast cancers: clinicopathologic significance in South-Asian population
por: Hashmi, Atif Ali, et al.
Publicado: (2018)

Biological significance of GATA3, cytokeratin 20, cytokeratin 5/6 and p53 expression in muscle-invasive bladder cancer
por: Wang, Chung-Chieh, et al.
Publicado: (2019)

Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer
por: Alix-Panabières, Catherine, et al.
Publicado: (2009)

Evaluation of miRNA 223/125a and COBLL1 Expressions and ROR-1 Levels as Reliable Markers in B- chronic Lymphocytic Leukemia
por: Hussein, Samia, et al.
Publicado: (2022)

Outcome of docetaxel in treatment of metastatic hormone-sensitive prostate cancer and correlation with hemoglobin, albumin, lymphocyte and platelets score
por: Taha, Heba F., et al.
Publicado: (2022)

Cytokeratin-18 in Diagnosis of HCC in Patients with Liver Cirrhosis
por: Ismail, Saber A, et al.
Publicado: (2017)

Detection of circulating tumor cells in blood of metastatic breast cancer patients using a combination of cytokeratin and EpCAM antibodies
por: Weissenstein, Ulrike, et al.
Publicado: (2012)

Clinicopathological Significance of Vimentin and Cytokeratin Protein in the Genesis of Squamous Cell Carcinoma of Cervix
por: Husain, Nazik Elmalaika O. S., et al.
Publicado: (2016)

Prognostic significance of post-preoperative tumor markers increments in patients with non-metastatic gastric cancer
por: Zhu, Xiao-Dong, et al.
Publicado: (2023)

Markers of metastatic colorectal cancer
por: Myśliwiec, Piotr, et al.
Publicado: (2019)

High OCT4A levels drive tumorigenicity and metastatic potential of medulloblastoma cells
por: Gonçalves da Silva, Patrícia Benites, et al.
Publicado: (2017)

Cytokeratin and CD56 aberrant co‐expression in diffuse large B‐cell lymphoma, NOS misinterpreted as metastatic neuroendocrine carcinoma by FNAC
por: Prevodnik, Veronika Kloboves, et al.
Publicado: (2022)

Forkhead box M1 over-expression and dachshund homolog 1 down-regulation as novel biomarkers for progression of endometrial carcinoma in Egyptian patients
por: Hafez, Abeer M., et al.
Publicado: (2021)

Cytokeratin Autoantibodies: Useful Serologic Markers for Toluene Diisocyanate-Induced Asthma
por: Ye, Young-Min, et al.
Publicado: (2006)

Role of Cytokeratin 20 as a Predictive and Prognostic Marker in Urothelial Neoplasms
por: Popov, Hristo, et al.
Publicado: (2022)

Immunohistochemical Studies of Cytokeratins and Differentiation Markers in Bovine Ocular Squamous Cell Carcinoma
por: Vala, Helena, et al.
Publicado: (2020)

Haematogenous cytokeratin 20 mRNA as a predictive marker for recurrence in oral cancer patients
por: Kawamata, H, et al.
Publicado: (1999)

Cutaneous presentation of metastatic pancreatic cancer
por: Abdelaziz, Mohammed, et al.
Publicado: (2022)

Significance of Matrix Metalloproteinase 9 Expression as Supporting Marker to Cytokeratin 19 mRNA in Sentinel Lymph Nodes in Breast Cancer Patients
por: Murawski, Marek, et al.
Publicado: (2016)

Clinical significance of BRAF mutations in metastatic melanoma
por: Chang, David Z, et al.
Publicado: (2004)

The prognostic significance of heparanase expression in metastatic melanoma
por: Vornicova, Olga, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_nk1d3e1pgmg2rkg2dkel8outf4